MDL | - |
---|---|
Molecular Weight | 207.23 |
Molecular Formula | C11H13NO3 |
SMILES | CC(N(C)CC1=CC2=C(OCO2)C=C1)=O |
Human Endogenous Metabolite |
SY-640 inhibits the number of liver-infiltrating cells and attenuates the increased expression of leukocyte function-associated antigen-1 on these cells
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
SY-640 (Oral; 150 mg/kg; once daily for 7 days) significantly inhibits Propionibacterium acnes and Lipopolysaccharide-induced liver injury, but a single administration is without effect
[1]
.
SY-640 (p.o.; 150 mg/kg; once daily for three days) significantly increases the liver microsomal cytochrome P-450 content and aminopyrine demethylase activity in mice. The hepatic microsomal aminopyrine demethylase activity is obviously inhibited two hours after oral administration of SY-640
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Liquid
Room temperature in continental US; may vary elsewhere.
Pure form | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 100 mg/mL ( 482.56 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 4.8256 mL | 24.1278 mL | 48.2556 mL |
5 mM | 0.9651 mL | 4.8256 mL | 9.6511 mL |
10 mM | 0.4826 mL | 2.4128 mL | 4.8256 mL |
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (12.06 mM); Clear solution